IL-1β activates the TLR2/MyD88/NF-κB pathway in Parkinson’s disease, leading to α-synuclein spreading in Parkinson’s disease (PD), multiple-system atrophy (MSA), and dementia with Lewy bodies [19]. Here, MYD88 is linked to multiple system atrophy.